We are live on !
Find out more
Tejara Capital Portfolio holdings
AUM
$205M
Turnover
61.11%
1-Year Est. Return
0.53%
This Fund
S&P 500
This Quarter Est. Return
-0.16%
1 Year Est. Return
+0.53%
3 Year Est. Return
+7.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$205M
AUM Growth
-$38.7M
(-16%)
Cap. Flow
-$36.2M
Cap. Flow % of AUM
Cap. Flow %
-17.71%
Top 10 Holdings %
Top 10 Hldgs %
59.27%
Holding
90
New
24
Increased
14
Reduced
20
Closed
31
Avg Time Held
0.7
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlas Energy Solutions
AESI
|
+$11.7M |
| 2 |
Establishment Labs
ESTA
|
+$6.71M |
| 3 |
Halliburton
HAL
|
+$6.08M |
| 4 |
The Mosaic Company
MOS
|
+$5.93M |
| 5 |
Cardiol Therapeutics
CRDL
|
+$3.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Maravai LifeSciences
MRVI
|
+$10M |
| 2 |
Global Payments
GPN
|
+$9.6M |
| 3 |
BILL Holdings
BILL
|
+$9.6M |
| 4 |
EPAM Systems
EPAM
|
+$7.84M |
| 5 |
Certara
CERT
|
+$4.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 52.34% |
| 2 | Healthcare | 21.22% |
| 3 | Technology | 11.29% |
| 4 | Materials | 7.25% |
| 5 | Industrials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Heron Therapeutics
HRTX
$62M
| $2.04M | 1% |
6,492,878
-17,917
| -0.3% | -$6.79K |
2022 Q4
15 quarters
|
|
27
Cameco
CCJ
$31.3B
| $1.72M | 0.84% |
+19,900
| New | +$1.88M |
2026 Q3
0 quarters
|
|
28
Corteva
CTVA
$6.13B
| $1.55M | 0.76% |
+19,900
| New | +$1.65M |
2026 Q3
0 quarters
|
|
29
Fiserv Inc
FISV
$32.7B
| $1.3M | 0.64% |
28,800
-25,300
| -47% | -$1.29M |
2026 Q2
1 quarter
|
|
30
Albemarle
ALB
$11.2B
| $1.3M | 0.64% |
+12,300
| New | +$1.53M |
2026 Q3
0 quarters
|
|
31
Westlake Corp
WLK
$8.03B
| $1.22M | 0.59% |
+19,500
| New | +$1.45M |
2026 Q3
0 quarters
|
|
32
Campbell Soup
CPB
$6.58B
| $1.17M | 0.57% |
59,200
+30,600
| +107% | +$678K |
2026 Q2
1 quarter
|
|
33
X-Energy Inc
XE
$3.35B
| $1.15M | 0.56% |
+81,200
| New | +$1.4M |
2026 Q3
0 quarters
|
|
34
General Mills
GIS
$17.9B
| $1.05M | 0.51% |
32,700
+14,500
| +80% | +$541K |
2026 Q2
1 quarter
|
|
35
ProPetro Holding
PUMP
$908M
| $1M | 0.49% |
+113,200
| New | +$1.29M |
2026 Q3
0 quarters
|
|
36
Intuit
INTU
$90.9B
| $993K | 0.49% |
3,600
-6,320
| -64% | -$1.99M |
2026 Q1
2 quarters
|
|
37
Tyler Technologies
TYL
$16.8B
| $981K | 0.48% |
+3,080
| New | +$1.02M |
2026 Q3
0 quarters
|
|
38
Weatherford International
WFRD
$6.2B
| $952K | 0.47% |
+12,100
| New | +$1.05M |
2026 Q3
0 quarters
|
|
39
QuidelOrtho
QDEL
$729M
| $952K | 0.47% |
90,290
-39,600
| -30% | -$581K |
2024 Q1
10 quarters
|
|
40
NOV
NOV
$6.35B
| $890K | 0.43% |
+47,500
| New | +$954K |
2026 Q3
0 quarters
|
|
41
Sandisk
SNDK
$133B
| $870K | 0.43% |
500
-450
| -47% | -$704K |
2026 Q2
1 quarter
|
|
42
Mereo BioPharma
MREO
$48.7M
| $810K | 0.4% |
2,014,508
-23,012
| -1% | -$7K |
2022 Q4
15 quarters
|
|
43
Vertex
VERX
$2.88B
| $729K | 0.36% |
+61,900
| New | +$784K |
2026 Q3
0 quarters
|
|
44
Apple
AAPL
$5.16T
| $719K | 0.35% |
+2,160
| New | +$694K |
2026 Q3
0 quarters
|
|
45
TherapeuticsMD
TXMD
$21.1M
| $664K | 0.32% |
327,282
-17,200
| -5% | -$36K |
2022 Q4
15 quarters
|
|
46
EyePoint Inc
EYPT
$27.5M
| $593K | 0.29% |
+181,300
| New | +$1.59M |
2026 Q3
0 quarters
|
|
47
Adobe
ADBE
$92.8B
| $499K | 0.24% |
2,080
-14,800
| -88% | -$3.71M |
2026 Q1
2 quarters
|
|
|
48
EPAM Systems
EPAM
$8.36B
| $498K | 0.24% |
4,600
-75,880
| -94% | -$7.84M |
2026 Q1
2 quarters
|
|
|
49
BILL Holdings
BILL
$4.64B
| $498K | 0.24% |
11,700
-207,700
| -95% | -$9.6M |
2026 Q1
2 quarters
|
|
50
Nebius Group N.V.
NBIS
$35B
| $495K | 0.24% |
+2,100
| New | +$452K |
2026 Q3
0 quarters
|
|
Similar funds
LC
Tejara Capital's Q3 2026 Portfolio in Review
As of Q3 2026, Tejara Capital held 90 positions worth $205M, down 16% from $243M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Tejara Capital withdrew a net $36.2M in Q3 2026, closing 31 positions and reducing 20 holdings. Its most notable exit was Maravai LifeSciences, an estimated $10M position sold in full.
By sector, the portfolio is most concentrated in Energy at 52% of assets, up from 32% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Tejara Capital opened a new position in Halliburton worth $5.67M.
- Tejara Capital's largest Q3 2026 buy was Halliburton: 178,400 shares worth $5.67M.
- Tejara Capital added most to Atlas Energy Solutions in Q3 2026, an estimated $11.7M increase.
- Tejara Capital's biggest Q3 2026 reduction was BILL Holdings, cutting an estimated $9.6M.
- Tejara Capital fully exited Maravai LifeSciences in Q3 2026, selling an estimated $10M.
- Tejara Capital's ten largest holdings make up 59% of its $205M portfolio in Q3 2026.
- Tejara Capital opened 24 new positions and closed 31 in Q3 2026.
- Tejara Capital's portfolio value fell 16% quarter-over-quarter to $205M.
Based on Tejara Capital's 13F filing for Q3 2026, filed 9 Nov 2026.